A drug discovery venture tackling next-generation cancer treatment using marine-derived compounds that improve tumor hypoxia while minimizing side effects. Already commercialized as veterinary medicine, it supports the lives of both humans and pets.
A startup building on ATR’s research achievements to develop products and services applying neuroscience, speech, and sensor technologies. It supports the dissemination of telecommunications technologies and talent development, accelerating the social implementation and industrial application of research outcomes.
By utilizing DNA as a functional organic material, we are developing a “DNA linker technology” that enables precise conjugation of antibodies with drugs and functional molecules, alongside related applications such as cell adhesion and enzyme-free nucleic acid detection. Our unique molecular design enhances the performance and multifunctionality of diverse materials, establishing foundational technologies for ADC drug development, 3D cell models, and diagnostic platforms. Furthermore, we expand these technologies into research support and collaborative R&D to accelerate industrial application and societal implementation.
Developing a system that leverages algal blooms to simultaneously capture and sequester CO₂, nitrogen, and phosphorus from water. Deployed for aquaculture, industrial wastewater, and sewage, it provides infrastructure that enables both decarbonization and resource circularity.
We provide real-time monitoring and predictive analytics for infrastructure assets such as bridges, roads, and towers. Powered by advanced evaluation technology originating from Kyoto University research, our solution enables timely maintenance to extend service life and reduce costs—helping create a safer, more sustainable society.
